These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 3243659)

  • 1. Plasma dapsone and its metabolite monoacetyldapsone levels in leprotic patients.
    Garg SK; Kumar B; Bakaya V; Lal R; Shukla VK; Kaur S
    Int J Clin Pharmacol Ther Toxicol; 1988 Nov; 26(11):552-4. PubMed ID: 3243659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A field trial among leprosy patients in Nigeria with depot injections of dapsone and monoacetyldapsone.
    Pieters FA; Woonink F; Zuidema J
    Int J Lepr Other Mycobact Dis; 1988 Mar; 56(1):10-20. PubMed ID: 3373080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of dapsone and amino acid prodrugs of dapsone.
    Pochopin NL; Charman WN; Stella VJ
    Drug Metab Dispos; 1994; 22(5):770-5. PubMed ID: 7835230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioavailability of dapsone on oral administration of Dapsomine--a comparative evaluation.
    Venkatesan K; Chauhan SL; Girdhar A; Girdhar BK
    Indian J Lepr; 1993; 65(2):157-61. PubMed ID: 8345229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of effect of proguanil on the pharmacokinetics of dapsone in healthy volunteers.
    Edstein MD; Rieckmann KH
    Chemotherapy; 1993; 39(4):235-41. PubMed ID: 8325124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic observations on dapsone in dermatitis herpetiformis.
    Swain AF; Ahmad RA; Rogers HJ; Leonard JN; Fry L
    Br J Dermatol; 1983 Jan; 108(1):91-8. PubMed ID: 6821646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disposition of dapsone and monoacetyldapsone in rats.
    Gordon GR; Peters JH; Ghoul DC; Murray JF; Levy L; Biggs JT
    Proc Soc Exp Biol Med; 1975 Nov; 150(2):485-92. PubMed ID: 1208566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacokinetics of dapsone and acetylated dapsone in serum and saliva.
    Lammintausta K; Kangas L; Lammintausta R
    Int J Clin Pharmacol Biopharm; 1979 Apr; 17(4):159-63. PubMed ID: 447435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of acetylator phenotype of the leprosy patient on the emergence of dapsone resistant leprosy.
    Raj PP; Aschhoff M; Lilly L; Balakrishnan S
    Indian J Lepr; 1988 Jul; 60(3):400-6. PubMed ID: 3058828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-acetylation polymorphism of dapsone in a Japanese population.
    Horai Y; Ishizaki T
    Br J Clin Pharmacol; 1988 Apr; 25(4):487-94. PubMed ID: 3382590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood dapsone levels in leprosy patients treated with acedapsone.
    George J; Balakrishnan S
    Indian J Lepr; 1986; 58(3):401-6. PubMed ID: 3794408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple-dose kinetics in healthy volunteers and in vitro antimalarial activity of proguanil plus dapsone.
    Edstein MD; Veenendaal JR; Rieckmann KH
    Chemotherapy; 1990; 36(3):169-76. PubMed ID: 2186899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute dapsone intoxication: a case with prolonged symptoms.
    Elonen E; Neuvonen PJ; Halmekoski J; Mattila MJ
    Clin Toxicol; 1979; 14(1):79-85. PubMed ID: 436385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple-dose pharmacokinetics and in vitro antimalarial activity of dapsone plus pyrimethamine (Maloprim) in man.
    Edstein MD; Rieckmann KH; Veenendaal JR
    Br J Clin Pharmacol; 1990 Aug; 30(2):259-65. PubMed ID: 2206787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The disposition of dapsone and monoacetyldapsone in the dog (38516).
    Peters JH; Gordon R; Biggs JT; Levy L
    Proc Soc Exp Biol Med; 1975 Jan; 148(1):251-5. PubMed ID: 1129265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous estimation of serum concentrations of dapsone, monoacetyldapsone, and pyrimethamine in Chinese men on maloprim for malaria prophylaxis using reversed-phase high performance liquid chromatography.
    Lee HS; Ti TY; Lee PS; Yap CL
    Ther Drug Monit; 1985; 7(4):415-20. PubMed ID: 3909534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Certain aspects of dapsone metabolism in leprosy patients as studied by high performance liquid chromatography (HPLC) and qualitative screening tests.
    Raj PP; Aschhoff M; De Wit M; Balakrishnan S; Lilly L
    Indian J Lepr; 1988 Apr; 60(2):215-24. PubMed ID: 3192970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-acetylation phenotyping using dapsone in a Jordanian population.
    Irshaid YM; al-Hadidi HF; Abuirjeie MA; Rawashdeh NM
    Br J Clin Pharmacol; 1991 Sep; 32(3):289-93. PubMed ID: 1777365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Armadillo as a model for studying chemotherapy of leprosy: preliminary studies.
    Dhople AM
    Indian J Lepr; 1986; 58(1):19-28. PubMed ID: 3745995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dapsone in saliva and plasma of man.
    Peters JH; Murray JF; Gordon GR; Gelber RH
    Pharmacology; 1981; 22(3):162-71. PubMed ID: 7208598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.